Opposing effects of 5,7-DHT infusions into the orbitofrontal cortex and amygdala on flexible responding

Cerebral Cortex

Volumn 20, Issue 7, 2010, Pages 1668-1675

  Man, M S ^a,b   Dalley, J W ^b,c,d   Roberts, A C ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UK   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

behavioral inhibition; prepotent response

Indexed keywords

5,7 DIHYDROXYTRYPTAMINE; SEROTONIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; APPETITE; ARTICLE; AUTOPSY; BEHAVIOR; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FOOD INTAKE; IN VIVO STUDY; MALE; MARMOSET; NONHUMAN; ORBITAL CORTEX; PRIORITY JOURNAL; TISSUE LEVEL;

5,7-DIHYDROXYTRYPTAMINE; AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; CALLITHRIX; CHOICE BEHAVIOR; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; EXTRACELLULAR FLUID; FEMALE; FOOD PREFERENCES; HYDROXYINDOLEACETIC ACID; INHIBITION (PSYCHOLOGY); MALE; MICRODIALYSIS; PREFRONTAL CORTEX; SEROTONIN; SEROTONIN AGENTS;

EID: 77955930509     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhp236     Document Type: Article

References (46)

1. Banks SJ, Eddy KT, Angstadt M, Nathan PJ, Phan KL. 2007. Amygdala-frontal connectivity during emotion regulation. Soc Cogn Affect Neurosci. 2:303-312.
2. Blier P, de Montigny C. 1998. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive compulsive disorder responses. Biol Psychiatry. 44:313-323.
3. Burghardt NS, Sullivan GM, McEwen BS, Gorman JM, LeDoux JE. 2004. The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry. 55:1171-1178.
4. Cannistraro PA, Wright CI, Wedig MM, Martis B, Shin LM, Wilhelm S, Rauch SL. 2004. Amygdala responses to human faces in obsessive-compulsive disorder. Biol Psychiatry. 56:916-920.
5. Cardinal RN, Parkinson JA, Lachenal G, Halkerston KM, Rudarakanchana N, Hall J, Morrison CH, Howes SR, Robbins TW, Everitt BJ. 2002. Effects of selective excitotoxic lesions of the nucleus accumbens core, anterior cingulated cortex and central nucleus of the amygdala on autoshaping performance in rats. Behav Neurosci. 116:553-567.
6. Carmichael ST, Price JL. 1995. Limbic connections of the orbital and medial prefrontal cortex in macaque monkeys. J Comp Neurol. 363:615-641.
7. Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC. 2004. Cognitive inflexibility after prefrontal serotonin depletion. Science. 304:878-880.
8. Clarke HF, Robbins TW, Roberts AC. 2008. Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex. J Neurosci. 28:10972-10982.
9. Clarke HF, Walker SC, Crofts HS, Dalley JW, Robbins TW, Roberts AC. 2005. Prefrontal serotonin depletion affects reversal learning but not attentional set shifting. J Neurosci. 25:523-528.
10. Clarke HF, Walker SC, Dalley JW, Robbins TW, Roberts AC. 2007. Cognitive inflexibility after prefrontal serotonin depletion is behav-iourally and neurochemically specific. Cereb Cortex. 17:18-27.
11. Cocarro EF. 1989. Central serotonin and impulsive aggression. Br J Psychiatry. Suppl. 8:52-62.
12. Cools R, Robinson OJ, Sahakian B. 2008. Acute tryptophan depletion in healthy volunteers enhances punishment prediction but does not affect reward prediction. Neuropsychopharmacology. 33:2291-2299.
13. Dalley JW, Theobald DE, Eagle DM, Passetti F, Robbins TW. 2002. Deficits in impulse control associated with tonically-elevated function in rat serotonergic prefrontal cortex. Neuropsychophar-macology. 26:716-728.
14. Dannlowski U, Ohrmann P, Bauer J, Kugel H, Baune BT, Hohoff C, Kersting A, Arolt V, Heindel W, Deckert J, et al. 2007. Serotonergic genes modulate anygdala activity in major depression. Genes Brain Behav. 6:672-676.
15. Dayan P, Huys QJM. 2009. Serotonin in affective control. Annu Rev Neurosci. 32:1-32.
16. De Leeuw AS, Westenberg HGM. 2008. Hypersensitivity of 5-HT2 receptors in OCD patients: an increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo. J Psych Res. 42:894-901.
17. Deakin JF. 1988. 5-HT2 receptors, depression and anxiety. Pharmacol Biochem Behav. 29:819-820.
18. Dias R, Robbins TW, Roberts AC. 1996. Dissociation in prefrontal cortex of affective and attentional shifts. Nature. 380:69-72.
19. Drevets WC. 2001. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr Opin Neurobiol. 11:240-249.
20. Fisher PM, Meltzer CC, Price JC, Coleman RL, Ziolko SK, Becker C, Moses-Kolko EL, Berga SL, Hariri AR. 2009. Medial prefrontal cortex 5-HT2A density is correlated with amygdala reactivity, response habituation, and functional coupling. Cereb Cortex. doi:10.1093/cercor/bhp022.
21. Forster GL, Feng N, Watt MJ, Korzan WJ, Mouw NJ, Summers CH, Renner KJ. 2006. Corticotropin-releasing factor in the dorsal raphe elicits temporally distinct serotonergic responses in the limbic system in relation to fear behavior. Neuroscience. 141:1047-1055.
22. Ghashghaei HT, Barbas H. 2002. Pathways for emotion: interactions of prefrontal and anterior temporal pathways in the amygdala of the rhesus monkey. Neuroscience. 115:1261-1279.
23. Ghashghaei HT, Hilgetag CC, Barbas H. 2007. Sequence of information processing for emotions based on the anatomic dialogue between prefrontal cortex and amygdala. Neuroimage. 34:905-923.
24. Harmer CJ, Mackay CE, Reid CB, Cowen PJ, Goodwin GM. 2006. Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry. 59:816-820.
25. Izquierdo A, Murray EA. 2005. Opposing effects of amygdala and orbital prefrontal cortex lesions on the extinction of instrumental responding in macaque monkeys. Eur J Neurosci. 22:2341-2346.
26. Izquierdo A, Murray EA. 2007. Selective bilateral amygdala lesions in rhesus monkeys fail to disrupt object reversal learning. J Neurosci. 27:1054-1062.
27. Joel D, Stein DJ, Schreiber R. 2008. Animal models of obsessive compulsive disorder: from bench to bedside via endophenotypes and biomarkers. In Animal and translational models for CNS discovery, Vol.1. Psychiatric disorders. McArthur R and Borsini F, editors. Oxford: Elsevier Academic Press, 133-164.
28. Jones B, Mishkin M. 1972. Limbic lesions and the problem of stimulus-reinforcement associations. Exp Neurol. 36:362-377.
29. Linnoila VM, Virkkunen M. 1992. Aggression, suicidality, and serotonin. J Clin Psychiatry. Suppl. 53:46-51.
30. Macmillan NA, Creelman CD. 1991. Detection theory: a user's guide. Cambridge: Cambridge University Press.
31. Man MS, Clarke HF, Roberts AC. 2009. The role of the orbitofrontal cortex and medial striatum in the regulation of prepotent responses to food rewards. Cereb Cortex. 19:899-906.
32. Meltzer H. 1989. Serotonergic dysfunction in depression. Br J Psychiatry. Suppl. 8:25-31.
33. Pezawas L, Meyer-Lindenberg A, Drabant EM, Verchinski BA, Munoz KE, Kolachana BS, Egan MF, Mattay VS, Hariri AR, Weinberger DR. 2005. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci. 6:828-834.
34. Reekie YL, Braesicke K, Man MS, Roberts AC. 2008. Uncoupling of behavioral and autonomic responses after lesions of the primate orbitofrontal cortex. Proc Natl Acad Sci USA. 105:9787-9792.
35. Saddoris MP, Gallagher M, Schoenbaum G. 2005. Rapid associative encoding in basolateral amygdala depends on connections with orbitofrontal cortex. Neuron. 46:321-331.
36. Saxena S, Rauch SL. 2000. Functional neuroimaging and the neuroanat-omy of obsessive-compulsive disorder. Psychiatr Clin North Am. 23:563-586.
37. Stalnaker TA, Franz TM, Singh T, Schoenbaum G. 2007. Basolateral amygdala lesions abolish orbitofrontal-dependent reversal impairments. Neuron. 54:51-58.
38. Stutzmann GE, LeDoux JE. 1999. GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning. J Neurosci. 19:RC8.
39. Szeszko PR, Robinson D, Alvir JM, Bilder RM, Lencz T, Ashtari M, Wu H, Bogerts B. 1999. Orbital frontal and amygdala volume reductions in obsessive compulsive disorder. Arch Gen Psychiatry. 56:913-919.
40. Tops M, Russo S, Boksem MAS, Tucker DM. 2009. Serotonin:modulator of a drive to withdraw. Brain Cognition. doi:10.1016/j.bandc.2009.03.009.
41. Thakore JH, O'Keane V, Dinan TG. 1996. d-Fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensi-tivity. Am J Psychiatry. 153:1460-1463.
42. Walker SC, Mikheenko YP, Argyle D, Robbins TW, Roberts AC. 2006. Selective prefrontal serotonin depletion impairs acquisition of a detour-reaching task. Eur J Neurosci. 23:3119-3123.
43. Walker SC, Robbins TW, Roberts AC. 2009. Differential contributions of dopamine and serotonin to orbitofrontal cortex function in the marmoset. Cereb Cortex. 19:889-898.
44. Winstanley CA, Theobald DE, Cardinal RN, Robbins TW. 2004. Contrasting roles of basolateral amygdala and orbitofrontal cortex in impulsive choice. J Neurosci. 24:4718-4722.
45. Winstanley CA, Theobald DE, Dalley JW, Cardinal RN, Robbins TW. 2006. Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex. 16:106-114.
46. Winstanley CA, Theobald DE, Dalley JW, Glennon JC, Robbins TW. 2004. 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology. 176:376-385.